[1] Khan MA, Kamal S, Khan S, et al. Systematic review and meta-analysis of the possible association between pharmacological gastric acid suppression and spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol, 2015, 27(11):1327-1336.
[2] Xu HB, Wang HD, Li CH, et al. Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients:a systematic review and meta-analysis. Genet Mol Res, 2015, 14(3):7490-7501.
[3] Koulaouzidis A, Bhat S, Saeed AA. Spontaneous bacterial peritonitis. World J Gastroenterol, 2009, 15(9):1042-1049.
[4] Cai ZH, Fan CL, Zheng JF, et al. Measurement of serum procalcitonin levels for the early diagnosis of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis. BMC Infect Dis, 2015,15:55.
[5] Cekin Y, Cekin AH, Duman A, et al. The role of serum procalcitonin levels in predicting ascitic fluid infection in hospitalized cirrhotic and noncirrhotic patients. Int J Med Sci, 2013, 10(10):1367-1374.
[6] Yuan LY, Ke ZQ, Wang M, et al. Procalcitonin and C-reactive protein in the diagnosis and prediction of spontaneous bacterial peritonitis associated with chronic severe hepatitis B. Ann Lab Med, 2013, 33(6):449-454.
[7] 刘丹,朱清静,万十千,等. 血清降钙素原联合C-反应蛋白检测诊断肝硬化并发自发性细菌性腹膜炎价值探讨.实用肝脏病杂志, 2015, 18(1):80-81.
[8] 陈静,段钟平,白丽,等. 不同类型肝病患者凝血因子变化规律及其与凝血状态的关系.中华肝脏病杂志,2012,20(3): 206-210.
[9] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2015年版).实用肝脏病杂志,2016,19(3):Ⅴ-ⅩⅩⅢ.
[10] 中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南. 实用肝脏病杂志,2018,21(1):21-31.
[11] Guo J, Shi J, Wang H, et al. Emerging gram-positive bacteria and drug resistance in cirrhosis patients with spontaneous bacterial peritonitis: A retrospective study. Exp Ther Med, 2019, 17(6):4568-4576.
[12] Duah A, Nkrumah KN.Spontaneous bacterial peritonitis among adult patients with ascites attending Korle-Bu Teaching Hospital. Ghana Med J, 2019, 53(1):37-43.
[13] Fiore M, Di Franco S, Alfieri A, et al. Spontaneous bacterial peritonitis caused by Gram-negative bacteria: an update of epidemiology and antimicrobial treatments. Expert Rev Gastroenterol Hepatol, 2019, 29:1-10.
[14] Hrml S, Parisinos C, Ryan J, et al.Effectiveness of intravenous albumin therapy to prevent spontaneous bacterial peritonitis, renal dysfunction and death in adults with cirrhosis: a protocol for a systematic review. BMJ Open, 2019, 9(1):e025664.
[15] Metwally K, Fouad T, Assem M, et al. Predictors of spontaneous bacterial peritonitis in patients with cirrhotic ascites. J Clin Transl Hepatol, 2018, 6(4):372-376.
[16] 方亚平, 陈杏林, 刘文芳, 等. 肝硬化腹水并发自发性细菌性腹膜炎的病原学及危险因素分析. 中华医院感染学杂志,2017,27(3):2924-2927.
[17] Musskopf MI, Fonseca FP, Gass J, et al. Prognostic factors associated within-hospital mortality in patients with spontaneous bacterial peritonitis. Ann Hepatol, 2012, 11(6):915-920.
[18] Melcarne L, Sopea J, Martínez-Cerezo FJ, et al. Prognostic factors of liver cirrhosis mortality after a first episode of spontaneous bacterial peritonitis. A multicenter study. Rev Esp Enferm Dig, 2018, 110(2): 94-101.
[19] 盛棋跃, 刘敏慧, 陈海君, 等. 降钙素原联合凝血因子预测肝硬化并发自发性细菌性腹膜炎预后的研究. 中华临床感染病杂志,2018,11(5): 353-358.
[20] 朱龙川, 朱萱. 血降钙素原和C-反应蛋白对肝硬化腹水非多形核细胞性自发性细菌性腹膜炎的诊断意义. 中华消化杂志, 2016, 36(3): 161-166. |